| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3435667 | American Journal of Obstetrics and Gynecology | 2010 | 8 Pages |
Abstract
USPC overexpressing HER-2/neu display greater in vitro sensitivity to platinum compounds when compared to low HER-2/neu expressors. Higher proliferative capability rather than increased drug resistance may be responsible for the adverse prognosis associated with HER-2/neu overexpression in USPC.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sarah N. MD, Emiliano PhD, Stefania PhD, Valsamo K. MD, Stacey L. PhD, Christine E. MD, Eric R. MS, Peter E. MD, Thomas J. MD, Alessandro D. MD,